Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02044289 · ClinicalTrials.gov registry record
MR Imaging Biomarkers of Disease Response to ECT (Electroconvulsive Therapy) in Depression
A clinical trial, sponsored by University of Arkansas.
- Completed
- Registry status
- 12
- Enrollment target
NCT02044289: Completed study, sponsored by University of Arkansas.
NCT02044289 is a clinical trial that has completed, run by University of Arkansas. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02044289 has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to (a) measure how brain structure, metabolism (how the brain uses energy), and function predict response to electroconvulsive therapy (ECT) for treatment of depression; and (b) measure how ECT changes brain metabolism and function. We will ask you to undergo magnetic resonance imaging (MRI) at three sessions: (1) prior to your first ECT therapy session, (2) after having 4-6 ECT therapy sessions, and (3) approximately two months following your first ECT therapy sessions.
Primary Outcome
clinical response will be measured by previously validated assessment tool (HAM-D); score 0-20 (normal to severely depressed)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-06 |
| Est. Completion | 2015-12 |
What the finished NCT02044289 record still lists
NCT02044289 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02044289 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02044289 about?
NCT02044289 is a clinical study titled "MR Imaging Biomarkers of Disease Response to ECT (Electroconvulsive Therapy) in Depression". The purpose of this study is to (a) measure how brain structure, metabolism (how the brain uses energy), and function predict response to electroconvulsive therapy (ECT) for treatment of depression; and (b) measure how ECT changes brain metabolism and function. We will ask you to undergo magnetic re...
What is the current status of trial NCT02044289?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2014-06. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT02044289?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia